Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 18.42% vs 10.41% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 3.45% vs 20.83% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 20.69% vs -3.33% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -50.00% vs 100.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Ishita Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 18.42% vs 10.41% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 78.22% vs -1.94% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 3.45% vs 20.83% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 100.00% vs 7.14% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 20.69% vs -3.33% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 105.88% vs 0.00% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -50.00% vs 100.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 100.00% vs -66.67% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






